| 注册
首页|期刊导航|中国临床药理学杂志|用LC-MS/MS法测定血清中左乙拉西坦的浓度

用LC-MS/MS法测定血清中左乙拉西坦的浓度

安迪 阎彦 王娜 张伟威 张伟东

中国临床药理学杂志2024,Vol.40Issue(4):603-606,4.
中国临床药理学杂志2024,Vol.40Issue(4):603-606,4.DOI:10.13699/j.cnki.1001-6821.2024.04.026

用LC-MS/MS法测定血清中左乙拉西坦的浓度

Determination of levetiracetam concentration in serum by LC-MS/MS

安迪 1阎彦 1王娜 1张伟威 1张伟东1

作者信息

  • 1. 秦皇岛市第一医院 药学部,河北 秦皇岛 066000
  • 折叠

摘要

Abstract

Objective To develop a method for determination of levetiracetam in human serum by LC-MS/MS,and it was applied to therapeutic drug monitoring in epilepsy patients.Methods Using levetiracetam-D6 as internal standard,the serum samples were tested after protein precipitation.The Kinetex XB-C18(50.0 mm x3.0 mm,2.6 μm)was used,the mobile phase consisted of methanol:0.01%formic acid water solution,gradient elution,the flow rate was 0.4 mL·min-1,and the column temperature was 40 ℃.The injection volume was 1 μL.Electron Spray Ionization source was applied and operated in multiple reaction monitoring mode.The quantitative analysis transitions were m/z 171.1→154.2(levetiracetam)and m/z 177.1→160.1(levetiracetam-D6).The specificity,lower limit of quantitation,linearity,precision,accuracy and stability were investigated.The method was applied to 82 cases of epilepsy patients for therapeutic drug monitoring.Results The calibration curve was y=0.573 7x+0.125 0(r=0.999 6),linear was within the range of 1-100 μg·mL-1 for levetiracetam in human serum.The relative standard deviation(RSD)of intra and inter precision were less than 3%.The recovery were between 93.67%-97.61%.The range of serum concentration of levetiracetam in 82 epilepsy patients was 1.14-22.07 μg·mL-1.Conclusions The method for determining levetiracetam concentration is simple,fast,sensitive,specific and accurate,which can be used for the therapeutic drug monitoring in epilepsy patients.

关键词

左乙拉西坦/液相色谱-串联质谱法/治疗药物监测

Key words

levetiracetam/liquid chromatography tandem-mass spectrometry/therapeutic drug monitoring

分类

医药卫生

引用本文复制引用

安迪,阎彦,王娜,张伟威,张伟东..用LC-MS/MS法测定血清中左乙拉西坦的浓度[J].中国临床药理学杂志,2024,40(4):603-606,4.

基金项目

河北省博士后基金资助项目(B2021003046) (B2021003046)

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文